Phase II study of antineoplastons A10 and AS2-1 in patients with carcinoma of the kidney
Phase of Trial: Phase II
Latest Information Update: 03 Oct 2017
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 03 Oct 2017 Last checked against ClinicalTrials.gov record.
- 27 Sep 2017 Status changed from active, no longer recruiting to discontinued.
- 16 Sep 2005 New trial record.